Related Experiment Video
Updated: Mar 22, 2026
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Transcranial Doppler Screening Among Children and Adolescents With Sickle Cell Anemia
Sarah L Reeves1, Brian Madden1, Gary L Freed1
1Child Health Evaluation and Research Unit, Department of Pediatrics, University of Michigan, Ann Arbor.
Insights
Transcranial Doppler (TCD) screening rates for children with sickle cell anemia increased from 22% to 44% between 2005 and 2010. However, rates remain low, highlighting opportunities to improve screening through healthcare interactions.
Area of Science:
- Pediatric Hematology
- Neurology
- Public Health
Background:
- Sickle cell anemia poses a high stroke risk in children and adolescents.
- Transcranial Doppler (TCD) screening identifies at-risk individuals.
- Administrative claims data can assess health services utilization.
Purpose of the Study:
- Assess feasibility of using Medicaid claims data to identify TCD screening receipt in children with sickle cell anemia.
- Describe TCD screening rates and identify intervention opportunities.
Main Methods:
- Retrospective cross-sectional study using Medicaid claims (2005-2010) from six states.
- Identified 4775 children (2-16 years) with sickle cell anemia.
- Used logistic regression to analyze predictors of TCD screening.
Main Results:
- TCD screening rates increased from 22% to 44% (P<.001) over the study period.
- Rates varied significantly by state.
- Older age decreased screening odds (OR=0.97); previous screening (OR=2.44) and well-child visits (OR=1.10) increased odds.
Conclusions:
- Despite recommendations, TCD screening rates for pediatric sickle cell anemia remain low.
- Healthcare interactions present opportunities to improve screening rates.
- Claims data analysis is valuable for population-based health services research.
Importance:
With transcranial Doppler (TCD) screening, we can identify children and adolescents with sickle cell anemia who are at the highest risk of stroke. An accurate claims-based method for identifying children and adolescents with sickle cell anemia was recently developed and validated that establishes the necessary groundwork to enable large population-based assessments of health services utilization among children and adolescents with sickle cell anemia using administrative claims data.
Objective:
To assess the feasibility of using administrative claims data to identify and describe the receipt of TCD screening among children and adolescents with sickle cell anemia and to characterize opportunities for intervention.
Design, Setting, And Participants:
Retrospective cross-sectional study using Medicaid claims data from 2005 to 2010. Medicaid claims data were obtained from the following states: Florida, Illinois, Louisiana, Michigan, South Carolina, and Texas. Children and adolescents 2 to 16 years of age with sickle cell anemia were identified by the presence of 3 or more Medicaid claims with a diagnosis of sickle cell anemia within a calendar year (2005-2010). A total of 4775 children and adolescents contributed 10 787 person-years throughout the study period. Data were analyzed in 2015. A subset of children and adolescents enrolled for 2 or more consecutive years was identified to examine potential predictors of TCD screening, which included age, sex, previous receipt of TCD screening, state of residence, and health services utilization (well-child visits, outpatient visits, emergency department visits, and inpatient visits).
Main Outcomes And Measures:
Receipt of TCD screening was assessed by year and state. Using logistic regression with generalized estimating equations, we included associated predictors in a multivariable model to estimate odds of TCD screening.
Results:
For a total of 4775 children and adolescents 2 to 16 years of age, TCD screening rates increased over the 6-year study period from 22% to 44% (P < .001); rates varied substantially across states. A subset of 2388 children and adolescents with sickle cell anemia (50%) was enrolled for 2 or more consecutive years. Each year of increasing age was associated with 3% lower odds of TCD screening (odds ratio, 0.97 [95% CI, 0.95-0.98]; P = .002). Previous receipt of TCD screening (odds ratio, 2.44 [95% CI, 2.11-2.81]; P < .001) and well-child visits (odds ratio, 1.10 [95% CI, 1.03-1.18]; P = .007) were associated with higher odds of receiving a TCD screening.
Conclusions And Relevance:
Despite national recommendations, TCD screening rates remain low. Successful strategies to improve TCD screening rates may capitalize on the numerous health care interactions among children and adolescents with sickle cell anemia.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
